A detailed history of Jump Financial, LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 74,787 shares of EOLS stock, worth $888,469. This represents 0.03% of its overall portfolio holdings.

Number of Shares
74,787
Previous 63,951 16.94%
Holding current value
$888,469
Previous $693,000 74.75%
% of portfolio
0.03%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.66 - $17.48 $115,511 - $189,413
10,836 Added 16.94%
74,787 $1.21 Million
Q2 2024

Aug 14, 2024

BUY
$10.45 - $13.76 $540,693 - $711,956
51,741 Added 423.76%
63,951 $693,000
Q1 2024

May 13, 2024

SELL
$9.99 - $14.91 $575,354 - $858,711
-57,593 Reduced 82.51%
12,210 $170,000
Q4 2023

Oct 21, 2024

BUY
$7.6 - $10.53 $234,057 - $324,292
30,797 Added 78.95%
69,803 $735,000
Q4 2023

Feb 07, 2024

BUY
$7.6 - $10.53 $234,057 - $324,292
30,797 Added 78.95%
69,803 $735,000
Q3 2023

Oct 21, 2024

BUY
$7.15 - $10.2 $75,117 - $107,161
10,506 Added 36.86%
39,006 $356,000
Q3 2023

Nov 07, 2023

BUY
$7.15 - $10.2 $278,892 - $397,861
39,006 New
39,006 $356,000
Q1 2023

Oct 21, 2024

SELL
$7.81 - $11.05 $276,872 - $391,733
-35,451 Reduced 55.43%
28,500 $241,000
Q1 2023

May 03, 2023

BUY
$7.81 - $11.05 $222,585 - $314,925
28,500 New
28,500 $241,000
Q3 2022

Nov 07, 2022

BUY
$7.76 - $13.72 $104,108 - $184,067
13,416 Added 35.77%
50,926 $410,000
Q2 2022

Aug 09, 2022

BUY
$10.22 - $13.94 $383,352 - $522,889
37,510 New
37,510 $435,000
Q1 2022

May 12, 2022

SELL
$5.22 - $11.78 $92,394 - $208,506
-17,700 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$5.37 - $8.38 $122,973 - $191,902
-22,900 Reduced 56.4%
17,700 $115,000
Q3 2021

Nov 12, 2021

BUY
$7.36 - $13.67 $298,816 - $555,002
40,600 New
40,600 $309,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $666M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.